glp-1 agonists anxiety side effects GI Adverse of Glucagon-Like Peptide-1 Receptor The risk of depression, anxiety,
Description
The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
Data are presented as medians (interquartile ranges) or frequencies (%), and Wilcoxon signed-rank tests and Mann-Whitney U tests were used for paired and nonpaired group comparisons, respectively
The Moro orange, known for its deep pigmentation due to a high concentration of anthocyanins, is thought to have originated in Sicily in the early 1800s
Learn how low-dose semaglutide and tirzepatide may support metabolism, menopause, inflammation, and autoimmune health.
This is where wellness starts to collide with pharma
